Neuroendocrine consequences of sleep-disturbances in type 2 diabetes patients with and without depression

Neuroendocrine consequences of sleep-disturbances in type 2 diabetes patients with and without depression - Depression, Diabetes and Insomnia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37594

Enrollment

220

Registered

2012-07-18

Start date

2012-07-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia Diabetes Depression

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Confirmed type-2-diabetes, 18- years and over

Exclusion criteria

Exclusion criteria: Severe substance abuse or dependence, severe language barrier, psychosis, acute suicidality

Design outcomes

Primary

Measure	Time frame
HbA1C	—

Secondary

Measure	Time frame
n.a.	—

Countries

Netherlands

Outcome results